Peru vs Uganda: Access to anti-retroviral drugs, male
Peru
79.0%
in 2024
Uganda
81.0%
in 2024
Peru rank
49th
Uganda rank
46th
Access to anti-retroviral drugs, male over time
- Peru
- Uganda
How they compare
Uganda currently reports 81.0% against 79.0% in Peru, a difference of 2.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Uganda ahead.
Peru ranks 49th and Uganda ranks 46th of 141 countries.
Uganda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Peru | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.2% | 7.6% | 1.4% | Uganda |
| 2010s | 43.1% | 44.3% | 1.2% | Uganda |
| 2020s | 74.4% | 75.6% | 1.2% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Peru or Uganda?
- Uganda, at 81.0% against 79.0% in Peru as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Peru and Uganda?
- 2.0%, with Uganda ahead.
- How many years of comparable data are there for Peru and Uganda?
- 25 years are reported by both, from 2000 to 2024.
- How do Peru and Uganda rank globally for access to anti-retroviral drugs, male?
- Peru ranks 49th and Uganda ranks 46th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.